Annexon to present data reinforcing the neuroprotective effects of anx007 and c1q inhibition in geographic atrophy at the arvo 2024 annual meeting

Additional data from the phase 2 archer trial demonstrating protection of visual acuity and anatomical structure following anx007 treatment will be featured as an oral presentation

ANNX Ratings Summary

ANNX Quant Ranking